Treatment of rhinitis
AssigneeAmpio Pharmaceuticals, Inc.
InventorDavid Bar-Or
Life of this patent
Estimating the term…
Abstract
The invention provides a method of treating rhinitis. The method comprises administering an effective amount of a pharmaceutical composition comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP) formulated for nasal administration. The invention also provides a pharmaceutical product comprising a DA-DKP containing composition.
Claims10
A method of reducing the severity of the symptoms of allergic rhinitis comprising administering an effective amount of a pharmaceutical composition comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP), to an animal in need thereof, wherein the DA-DKP is in a composition prepared by removing albumin from a solution of a human serum albumin composition, wherein the effective amount of the DA-DKP in the composition is about 100 μg to about 3000 μg per day.
Dependencies are inferred from the claim text.